Name | 5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
---|---|
Synonyms |
Rivoglitazone
2,4-Thiazolidinedione, 5-[[4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]phenyl]methyl]- Rivoglitazone [USAN] 5-{4-[(6-Methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione UNII:3A3N0634Q6 Rivoglitazone [USAN:INN] 5-[4-(6-Methoxy-1-methylbenzimidazol-2-yl-methoxy)benzyl]-thiazolidine-2,4-dione (5R)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}1,3-thiazolidine-2,4-dione UNII-3A3N0634Q6 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl] thiazolidine-2,4-dione (5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidin-2,4-dione) |
Description | Rivoglitazone is a thiazolidinedione-derivative PPARγ agonist for the treatment of type 2 diabetes mellitus. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 669.3±40.0 °C at 760 mmHg |
Molecular Formula | C20H19N3O4S |
Molecular Weight | 397.448 |
Flash Point | 358.6±27.3 °C |
Exact Mass | 397.109619 |
PSA | 107.75000 |
LogP | 2.95 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.683 |